Pfizer Stock News

The Food and Drug Administration is expected to authorize a Pfizer COVID-19 vaccine booster for all adults as early as Thursday as new cases are rising again around the country. Also, desperate migrants clashed with police at the border between Poland and Belarus, where tensions have exploded in recent days. All that and all that matters in today''s Eye Opener.

The US company, Pfizer, announced, that it will allow low- and middle-income countries across the world to manufacture and distribute its new anti-Covid 19 drugs at low cost. The move comes as an attempt to increase global supply in 95 poor countries, while this move helps treat patients with the Coronavirus (known also as COVID-19). []

The US Food and Drug Administration has said it would review "as expeditiously as possible" Pfizer''s request to authorise booster doses of Covid-19 vaccine in all adults.

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE), a multinational pharmaceutical and biotechnology corporation, said Wednesday that Frank D''Amelio would retire from his role as Chief Financial Officer

The time period for taking the booster dose of the COVID-19 vaccine has been reduced from eight months to six months in Oman. The Ministry of Health would like to emphasise the continuity of giving the booster dose and the third dose of the Covid-19 vaccine (Pfizer BioNTech) to the target groups, regardless of The post Oman: Interval for receiving COVID-19 booster dose shortened appeared first on Gulf Insider .

ABC News (Australia) published this video item, entitled Read more

SIDE effects of the Covid booster vaccine are likely to be worse for millions of people, data suggests. Mixing the AstraZeneca vaccine with the Pfizer jab has shown to cause more symptoms like fatigue than any other combination. However, it is no reason to avoid getting the top-up shot, which drives protection against Covid back []

If you thought Pfizer was raking it in with megablockbuster sales of its BioNTech-partnered Covid-19 vaccine last projected at $36 billion for 2021 think again. As the pharma giant sends off its EUA submission for its antiviral pill to the FDA, the Washington Post, New York Times and

Pfizer Inc. unveiled on Wednesday that its Chief Financial Officer (CFO) Frank D''Amelio will retire from his position after spending close to 15 years in the company. In a statement, Pfizer expla

Pfizer shares pared some of its earlier gains Wednesday after the drugmaker said its long-serving CFO would step down in the coming months.

Pfizer Inc said on Wednesday Frank D''Amelio will retire from his position as chief financial officer and executive vice president of global supply after nearly 15 years at the company.

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that Frank DAmelio will retire from his position as Chief Financial Officer and Executive Vice President of Global Supply at Pfizer after a nearly 15 year distinguished career with the Company. Pfizer has initiated an external search for a new Chief Financial Officer and DAmelio has agreed to stay on board through this process and serve in a consulting role through the transition. With DAmelios planned departure, and his sig

Consumers are planning to splurge over the holidays, Apple on pace to set new iPhone sales record, Pfizer seeks FDA authorization for Covid-19 pill, and other news to start your day.

Study carried out by researchers at Johns Hopkins Medicine has shown that helper T cells produced by people who received either of Pfizer/BioNTech or Moderna vaccines for covid-19, persist six months after vaccination and recognize and help protect against the delta variant of SARS-CoV-2